硕腾 ZTS

Kristin C. Peck is the Chief Executive Officer of Zoetis and a Director, having served as a Director since October 2019. Career Highlights: Zoetis Inc. -- a leading global producer of medicine and vaccinations for pets and livestock: Chief Executive Officer (2020-present); Executive Vice President and Group President, U.S. Operations, Business Development and Strategy (2018-2019); Executive Vice President and President, U.S. Operations (2015-2018). Pfizer Inc. -- a global pharmaceutical company: Executive Vice President, Worldwide Business Development and Innovation (2004-2012). Education: Bachelor's degree from Georgetown University; Master of Business Administration from Columbia Business School. Kristin C. Peck currently serves on the board of directors of BlackRock (since September 2021) and is a member of the board of directors of Business Roundtable (since January 2026). She previously served as a member of the board of directors of Thomson Reuters.

Mr. Brannan has served as our Executive Vice President and Chief Commercial Officer since November 2024. He served as our Executive Vice President, Group President International Operations, Aquaculture and Global Diagnostics from November 2022 to November 2024. He served as our President of International Operations from June 2021 to November 2022. He served as our Senior Vice President of the U.K., Ireland and Nordics Cluster from 2016 to 2021. Mr. Brannan joined Zoetis from Molnlycke Health Care where he most recently served as the Surgical Business Director and General Manager for the U.K. and Ireland.

Ms. Lagano has served as our Executive Vice President, General Counsel and Corporate Secretary since May 2024. She served as our Executive Vice President and Chief Human Resources Officer from November 2012 and in January 2020 she took on responsibility for Global Operations and Security functions. She previously had oversight of the company's Corporate Communications function from 2015 to 2019. Ms. Lagano joined Pfizer in 1997 and held various positions, including Senior Vice President, Global Compensation, Benefits and Wellness and Senior Director, Business Transactions, Pfizer Worldwide Human Resources.

Frank A. D'Amelio is an Independent Director of Zoetis, having served since July 2012. He is the former Executive Vice President and Chief Financial Officer of Pfizer Inc. Career Highlights: Pfizer Inc. -- a global pharmaceutical company: Executive Vice President and Chief Financial Officer (2020-2022); Executive Vice President, Global Supply and Business Operations (2020-2021); Executive Vice President, Business Operations and Global Supply and Chief Financial Officer (2018-2020); Executive Vice President, Business Operations and Chief Financial Officer (2010-2018); Senior Vice President and Chief Financial Officer (2007-2010). Alcatel-Lucent, S.A. -- a global telecommunications equipment company: Senior Executive Vice President of Integration and Chief Administrative Officer (2006-2007). Lucent Technologies -- a telecommunications equipment company: Chief Operating Officer (2005-2007); Executive Vice President, Administration and Chief Financial Officer (2001-2006). Education: Bachelor's degree in Accounting from St. Peter's College; Master of Business Administration in Finance from St. John's University. Frank A. D'Amelio currently serves on the boards of directors of Humana Inc. (since September 2003), Hewlett Packard Enterprise (since January 2023) and Viatris Inc. (since May 2025), with previous service on the boards of Catalent Inc. and the National Advisory Board of JPMorgan Chase & Co.

On October 8, 2026, the Board of Directors of Zoetis Inc.appointed Iris Knobloch to the Board, effective as of December 1, 2026. Ms. Knobloch has served as President of the Festival de Cannes, a leading international film festival, since July 2022 and is the first woman to hold the position. From 2021 to July 2022, she served as Chair and CEO of I2PO S.A. prior to its business combination with Deezer S.A., a global music streaming platform, when she transitioned to Deezer's Board of Directors where she has served as its Chair of the Board since January 2023. Ms. Knobloch previously held senior executive positions at WarnerMedia and its predecessor companies, global media and entertainment businesses, including as President of WarnerMedia in France, Germany, the Benelux, Austria and Switzerland. Earlier in her career, Ms. Knobloch was responsible for Time Warner's International Relations and Strategic Policy for Europe and practiced law with O'Melveny & Meyers and Noerr, Stiefenhofer & Lutz. She has served as a director of Lazard, Inc., a global financial advisory and asset management firm, since April 2018, and Vail Resorts, Inc., a global hospitality business, since February 2024. Ms. Knobloch has previously served on the boards of Accor S.A., LVMH Moet Hennessy Louis Vuitton, SE, Central European Media Enterprises N.V. and Axel Springer SE. She is also a Governor of the American Hospital of Paris and a member of the Supervisory Board of the BMW Foundation Herbert Quandt, a nonprofit foundation dedicated to advancing responsible leadership and contributing to peaceful, just and sustainable societies. She holds a Doctorate in Law from Ludwig-Maximilians-Universitaet and a Master of Laws from New York University.

On August 6, 2026, Zoetis Inc. announced that James Saccaro has been appointed as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.Mr. Saccaro, has served as Vice President and Chief Financial Officer of GE HealthCare Technologies Inc. since June 2023. He previously served as Executive Vice President and Chief Financial Officer of Baxter International Inc. from July 2015 to May 2023. Mr. Saccaro received a bachelor's degree in economics and master's degree in engineering-economic systems from Stanford University.

Mark Stetter is an Independent Director of Zoetis, having served since May 2025. He is the Dean of the University of California, Davis School of Veterinary Medicine. Career Highlights: University of California, Davis School of Veterinary Medicine: Dean and Professor (2021-present). Colorado State University, College of Veterinary Medicine and Biomedical Sciences: Dean and Professor (2012-2021). The Walt Disney Company -- a leading global entertainment company: Director of Animal Operations (2009-2012); Director of Animal Health (2001-2009); various senior roles (1997-2001). Education: Bachelor of Science degree in Biochemistry and Chemistry from the University of Illinois at Champaign-Urbana; Doctor of Veterinary Medicine from the University of Illinois at Champaign-Urbana.

Sanjay Khosla is an Independent Director of Zoetis, having served since June 2013. He is the former EVP and President, Developing Markets of Mondelez International, Inc. Career Highlights: Bunnik LLC -- a management consulting firm: Chief Executive Officer (2013-present). Boston Consulting Group -- a leading global consulting firm: Senior Advisor (2013-2024). Mondelez International, Inc. -- a global food, beverage and snack company: Executive Vice President and President, Developing Markets (2012-2013). Kraft Foods (now Mondelez International) -- a global food, beverage and snack company: President, Developing Markets (2007-2012). Fonterra -- a global dairy company: Managing Director (2004-2006). Unilever -- a global consumer products company: various roles during 27+ year career. Education: Bachelor's degree in Electrical Engineering from the Indian Institute of Technology in New Delhi; Completed the Advance Management Program at Harvard Business School. Sanjay Khosla has previously served on the boards of directors of Best Buy, Inc. and NIIT, Ltd, and currently serves on several private company boards of directors including the board of directors of Qualsights (since 2022).

Gregory Norden is an Independent Director of Zoetis, having served since January 2013. He is the former Chief Financial Officer of Wyeth. Career Highlights: Wyeth (acquired by Pfizer in 2009) -- a global pharmaceutical and healthcare products company: Chief Financial Officer (2007-2009); Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals, Inc. (2000-2007); various senior positions (1989-2000). Arthur Andersen & Co. -- a global accounting firm: Audit Manager (1983-1989). G9 Capital Group LLC -- provider of corporate advisory services to companies, family offices and leading venture capital and private equity firms: Managing Director (2010-2025). Education: Bachelor's degree in Management and Economics from State University of New York at Plattsburgh; Master of Science in Accounting from LIU Post. Gregory Norden currently serves on the board of directors of Praxis Precision Medicines, Inc. (since March 2019) and Royalty Pharma plc (since June 2020).

Paul M. Bisaro is an Independent Director of Zoetis, having served since May 2015. He is the former Executive Chairman of Amneal Pharmaceuticals, Inc. Career Highlights: Amneal Pharmaceuticals, Inc. -- a global specialty pharmaceutical company: Executive Chairman (2018-2019). Impax Laboratories, Inc. -- a specialty pharmaceutical company: President and Chief Executive Officer (2017-2018). Allergan plc (formerly Actavis plc) -- a global pharmaceutical company: Executive Chairman of the Board of Directors (2014-2016). Actavis (formerly Watson Pharmaceuticals) -- a global pharmaceutical company: Board Chairman, President and Chief Executive Officer (2013-2014); President, Chief Executive Officer and Board Member (2007-2013). Barr Pharmaceuticals, Inc. -- a global specialty and generic drug manufacturer: President, Chief Operating Officer and Board Member (1999-2007); Senior Vice President - Strategic Business Development (1997-1999); General Counsel (1992-1999). Education: Bachelor's degree in General Studies from the University of Michigan; Juris Doctor from The Catholic University of America. Paul M. Bisaro currently serves on the board of directors of Myriad Genetics, Inc. (since October 2022) and Keenova Therapeutics plc (formerly Mallinckrodt plc) (since July 2025 and previously from 2022-June 2025).

Stephanie Tilenius is an Independent Director of Zoetis, having served since December 2025. She is the founder of Peak Health and founder and former CEO of Vida Health, Inc. Career Highlights: Peak Health -- a company in the longevity AI space: Founder (2024-present). Vida Health, Inc. -- a B2B chronic care platform: Founder and Chief Executive Officer (2014-2023). Google Inc. -- a global technology company offering search and advertising: Vice President of Global Commerce and Payments (2010-2012). eBay Inc. -- a leading global e-commerce platform: Senior Vice President, eBay.com and Global Product (2008-2010). PayPal Holdings, Inc. -- a global technology platform for digital payments: Vice President of Global Merchant Services (2003-2008). Education: Bachelor's degree in Economics from Brandeis University; Master's degree in International Economics and Finance from Brandeis University; Master's in Business Administration from Harvard University. Stephanie Tilenius currently serves on the board of directors of Seagate Technology Holdings plc (since 2021).

Vanessa Broadhurst is an Independent Director of Zoetis, having served since July 2022. She is the Executive Vice President, Global Corporate Affairs, at Johnson & Johnson. Career Highlights: Johnson & Johnson -- a global pharmaceutical and healthcare company: Executive Vice President, Global Corporate Affairs (2021-present); Company Group Chairman, Global Commercial Strategy for Pharmaceuticals (2019-2021); President, Cardiovascular and Metabolism (2017-2018); various senior leadership roles (2017). Amgen Inc. -- a global biotechnology company: General Manager, Cardiovascular and Bone Business Units (2014-2017); General Manager, Inflammation and Cardiovascular Business Units (2013-2014). Novartis AG -- a global pharmaceutical company: Head, Global Gastroenterology Marketing (2003-2005). Abbott Laboratories -- a global healthcare company: various roles of increasing responsibility (1994-2003). Education: Bachelor of Arts degree from the University of Colorado; Master of Business Administration from the Ross School of Business at the University of Michigan (Consortium Fellow).

Willie M. Reed is an Independent Director of Zoetis, having served since March 2014. He is the Dean Emeritus, Professor of Comparative Pathobiology at the College of Veterinary Medicine at Purdue University. Career Highlights: Purdue University, College of Veterinary Medicine: Dean Emeritus, Professor of Comparative Pathobiology (2024-present); Dean (2007-2024); Chief, Avian Diseases Diagnostic Service (1985-1990); Assistant Professor of Veterinary Pathology (1982-1987); Associate Professor of Veterinary Pathology (1987-1990). Michigan State University: Professor of Veterinary Pathology, Chairperson of the Department of Diagnostic Investigation (1997-2006); Director of the Diagnostic Center for Population and Animal Health (1990-2006); Assistant Director of the Animal Disease Diagnostic Laboratory (1985-1990). Professional Leadership: President, American Association of Veterinary Medical Colleges; President, American Association of Veterinary Laboratory Diagnosticians; President, American Association of Avian Pathologists; Chair, American Veterinary Medical Association Council on Research. Education: Bachelor's degree in Animal and Poultry Diseases from Tuskegee University; Doctor of Veterinary Medicine from Tuskegee University; Ph.D. in Veterinary Pathology from Purdue University.

Gavin D.K. Hattersley is an Independent Director of Zoetis, having served since April 2024. He is the former President and Chief Executive Officer at Molson Coors Beverage Company. Career Highlights: Molson Coors Beverage Company -- a global brewing beverage company: President and Chief Executive Officer and Board of Directors member (2019-2025); Chief Financial Officer (2012-2015). MillerCoors -- former U.S. division of Molson Coors: Chief Executive Officer (2015-2019); Executive Vice President and Chief Financial Officer (2008-2012). Miller Brewing Company -- a global brewing beverage company: Senior Vice President of Finance (2002-2008); Executive Vice President, Administration and Chief Financial Officer (2001-2006). The South African Breweries Limited -- a global brewing beverage company: Chief Financial Officer (1999-2002); various financial management positions (1997-1999). Education: Honors degree in Accounting Science and a Bachelor's degree from the University of South Africa. Gavin D.K. Hattersley currently serves on the board of directors of McCormick & Company (since January 2026).

Michael B. McCallister is the Chairman of the Board and an Independent Director of Zoetis, having served as a Director since January 2013 and as Board Chair since June 2013. He is the former Chairman of the Board and CEO of Humana Inc. Career Highlights: Humana Inc. -- a health insurance and healthcare services company: Chairman of the Board (2010-2013); Chief Executive Officer (2000-2012); various roles of increasing responsibility (1974-2000). Education: Bachelor's of Science degree in Accounting from Louisiana Tech University; Master of Business Administration from Pepperdine University. Michael B. McCallister currently serves on the board of directors of AT&T (since February 2013). He formerly served on the board of directors of National City Corp. and on the board of the Business Roundtable, where he was Chairman of its Health and Retirement Task Force.

Antoinette R. Leatherberry is an Independent Director of Zoetis, having served since December 2020. Career Highlights: Deloitte -- an industry-leading consulting, audit, tax and advisory services company: Partner (2007-2020); President, Deloitte Foundation (2016-2020). Education: Bachelor's degree in Mechanical Engineering from Boston University; Master of Business Administration in Operations Management and Supervision from Northeastern University; Doctor of Education (EdD) from Widener University. Antoinette R. Leatherberry currently serves on the board of directors of Digital Direct Holdings (since February 2022). Additional board service includes current membership on multiple private company boards of directors, including STRIVE (since 2022) and the American Family Insurance Mutual Holding Company (since 2020) and the advisory board of the Ellig Group (since 2022), and as member of the Widener University Board of Trustees and the Boston University Board of Trustees.

Dr. Esch has served as our Executive Vice President and President, Research and Development since January 2026. Previously, he served as our Senior Vice President of Global Therapeutics from May to December 2025. Dr. Esch joined Zoetis in 2014 and held various positions, including Vice President, Global Therapeutics and Executive Director, Research. Prior to Zoetis, Dr. Esch spent over 10 years as a practicing veterinarian and practice owner.

Mr. Ashton has served as our Executive Vice President and President, Global Manufacturing and Supply since May 2022. Mr. Ashton joined Zoetis in 2020 as Head of Global External Supply, where he led all aspects of the company's global external manufacturing network, overseeing CMOs to keep pace with customer demand. Mr. Ashton brings more than 25 years of global experience in areas of production, supply chain, external manufacturing, procurement, network strategy and execution for major international companies including GSK, Babcock International and Merck.

Ms. Fuller has served as our Executive Vice President, Chief Human Resources Officer and Global Operations since August 2024. Prior to joining Zoetis, Ms. Fuller was Chief People Officer at PVH Corp. Prior to PVH, Ms. Fuller was the Vice President of Global Talent and Organizational Effectiveness for Nike, Inc. and held key leadership positions at Avon and PepsiCo.

Mr. Sarbaugh has served as our Executive Vice President and Chief Digital & Technology Officer since November 2024. He served as our Chief Information Officer from March 2023 to November 2024. Prior to joining Zoetis, he was VP, Information Technology at Biogen, overseeing all aspects of Infrastructure, IT Operations and Enterprise Architecture globally. Previously, he held various corporate leadership roles at Eli Lilly and Company, including Head of IT Infrastructure and Enabling Functions and Regional CIO for Lilly's U.S. Commercial, Southeastern and Central Eastern European businesses.

Ms. Driscoll has served as our Executive Vice President and Head of Global Strategy, Commercial and Business Development since November 2022. She also has had oversight for the company's Global BioDevices business since February 2023. Previously, she served as our Senior Vice President, Business Development from January 2020 to November 2022. She served as our Vice President, Business Development and Commercial Alliances from 2016 to January 2020. Ms. Driscoll joined Zoetis in February 2016, from Procter & Gamble Company, where she worked for more than 20 years running Global Business Development, Mergers & Acquisitions and Alliance organizations for their consumer healthcare and pharmaceuticals businesses.

Ms. Ferran Astorga has served as our Executive Vice President, Corporate Affairs and Chief Sustainability Officer since January 2022 and also serves as President of the Zoetis Foundation. She joined Zoetis in September 2020 as Vice President, Head of Sustainability. Prior to joining Zoetis, Ms. Ferran Astorga was Vice President of Corporate Responsibility at the Ascena Retail Group where she served since 2015 leading the global team responsible for strategic enterprise initiatives, including supply chain compliance, sustainability and corporate philanthropy. Ms. Ferran Astorga held a variety of leadership roles with increasing responsibility at ANN INC., a women's fashion retail company that was acquired by Ascena Retail Group.